Recent Blog Posts

View Post: Rapid PSA Decline After Docetaxel Chemotherapy is Associated with ...
11 Nov 2009 by Joel  
A chart review performed at the Department of Internal Medicine, University of Alberta, Edmonton, AB. concluded that the a quick rate of initial PSA decline in men with hormone refractory prostate cancer receiving docetaxel chemotherapy ...
View Blog: Advanced Prostate Cancer - http://advancedprostatecancer.net/

---

View Post: RCT: Adjuvant capecitabine in combination with docetaxel and ...
10 Nov 2009
The study involved 1500 women with axillary node-positive or high-risk node-negative breast cancer randomised to either 3 cycles of capecitabine and docetaxel followed by 3 cycles of cyclophosphamide, epirubicin, and capecitabine ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: HELLO CRETE
21 Nov 2009 by Dr. NICK  
BACKGROUND: The purpose of this study was to compare docetaxel plus epirubicin versus docetaxel plus capecitabine combinations as front-line treatment in women with advanced breast cancer (ABC). PATIENTS AND METHODS: Previously ...
View Blog: CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/

---

View Post: Hospira Completes Decentralised Procedure for Generic Docetaxel ...
25 Oct 2009 by Prne  
Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced the completion of decentralised procedure (DCP) for generic docetaxel, and expects to launch across most of Europe between now and the ...
View Blog: PR Hub - http://blog.taragana.com/pr/

---

View Post: Docetaxel-induced photolichenoid eruption Vasudevan B, Sawhney M ...
12 Nov 2009 by Vasudevan Biju, Sawhney MPS, Sharma Nitu  
A diagnosis of photolichenoid eruption to docetaxel was thus confirmed. The medication was stopped and replaced by estramustine phosphate. Sunscreen, topical corticosteroid cream and tab Avil were prescribed. The lesions regressed in ...
View Blog: Table of Contents : Indian Journal of Pharmacol... - http://www.ijp-online.com/currentissue.asp

---

View Post: Threshold Pharmaceuticals Presents Interim Prostate Cancer Data ...
18 Nov 2009
Several years ago we furthered the support for the rationale of using TH-302 to treat prostate cancer when TH-302 was combined with docetaxel in a preclinical metastatic model of prostate cancer and eradicated all signs of disease," ...
View Blog: Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html

---

View Post: Identification of Candidate Biomarkers of Therapeutic Response to ...
1 Oct 2009 by Zhao, L., Lee, B. Y., Brown, D. A., Molloy,...  
Docetaxel chemotherapy improves symptoms and survival in men with metastatic hormone-refractory prostate cancer (HRPC). However, ~50% of patients do not respond to Docetaxel and are exposed to significant toxicity without direct benefit ...
View Blog: Cancer Research current issue - http://cancerres.aacrjournals.org/

---